Literature DB >> 1588833

Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals.

B Marescau1, D R Deshmukh, M Kockx, I Possemiers, I A Qureshi, P Wiechert, P P De Deyn.   

Abstract

Guanidino compound levels were quantitatively determined in serum, urine, liver, kidney, and brain of man and of some ureotelic animals. The guanidino compounds were separated over a cation exchange resin, using sodium citrate buffers, and detected with the fluorescence ninhydrin method. Species-specific differences in the levels of some guanidino compounds in the studied ureotelic animals are shown. alpha-Keto-delta-guanidinovaleric acid is a naturally occurring guanidino compound in ureotelic animals, and is not restricted to the pathobiochemistry of hyperargininemic patients. The fasting serum levels observed in beagles are the same as those found in hyperargininemic patients. In serum, liver, and kidney, the homoarginine, beta-guanidinopropionic acid, and gamma-guanidinobutyric acid levels are the highest in rats. The last two compounds have the highest levels of the studied guanidino compounds, with the exception of creatinine, in kidney. Specific high levels of gamma-guanidinobutyric acid and argininic acid are found in brain of rabbits.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588833     DOI: 10.1016/0026-0495(92)90213-t

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  25 in total

1.  Urinary metabolomics reveals novel interactions between metal exposure and amino acid metabolic stress during pregnancy.

Authors:  Mu Wang; Wei Xia; Hongbin Liu; Fang Liu; Han Li; Huailong Chang; Jie Sun; Wenyu Liu; Xiaojie Sun; Yangqian Jiang; Hongxiu Liu; Chuansha Wu; Xinyun Pan; Yuanyuan Li; Weiqing Rang; Songfeng Lu; Shunqing Xu
Journal:  Toxicol Res (Camb)       Date:  2018-07-24       Impact factor: 3.524

2.  S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy.

Authors:  I Barić; M Cuk; K Fumić; O Vugrek; R H Allen; B Glenn; M Maradin; L Pazanin; I Pogribny; M Rados; V Sarnavka; A Schulze; S Stabler; C Wagner; S H Zeisel; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 3.  Creatine kinase, energy reserve, and hypertension: from bench to bedside.

Authors:  Lizzy M Brewster
Journal:  Ann Transl Med       Date:  2018-08

4.  Disturbed metabolism of guanidino compounds characterized by elevated excretion of beta-guanidinopropionic acid and gamma-guanidinobutyric acid--an effect of vigabatrin treatment?

Authors:  A Schulze; E Mayatepek; S Frank; B Marescau; P P De Deyn; P Bachert
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

5.  Secretion of homoarginine into the gut of chickens.

Authors:  K Angkanaporn; V Ravindran; Y Mollah; W L Bryden
Journal:  Vet Res Commun       Date:  1997-04       Impact factor: 2.459

6.  S-adenosylhomocysteine hydrolase deficiency in a 26-year-old man.

Authors:  N R M Buist; B Glenn; O Vugrek; C Wagner; S Stabler; R H Allen; I Pogribny; A Schulze; S H Zeisel; I Barić; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2006-05-30       Impact factor: 4.982

7.  Behavioural deficits during the acute phase of mild renal failure in mice.

Authors:  M Al Banchaabouchi; R D'Hooge; B Marescau; P P De Deyn
Journal:  Metab Brain Dis       Date:  1999-09       Impact factor: 3.584

Review 8.  Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins.

Authors:  Ken-ichi Hosoya; Masanori Tachikawa
Journal:  Clin Exp Nephrol       Date:  2011-05-25       Impact factor: 2.801

9.  Guanidino acids act as rho1 GABA(C) receptor antagonists.

Authors:  Mary Chebib; Navnath Gavande; Kit Yee Wong; Anna Park; Isabella Premoli; Kenneth N Mewett; Robin D Allan; Rujee K Duke; Graham A R Johnston; Jane R Hanrahan
Journal:  Neurochem Res       Date:  2009-04-23       Impact factor: 3.996

10.  Sodium citrate supplementation in inborn argininosuccinate lyase deficiency: a study in a 5-year-old patient under total parenteral nutrition.

Authors:  C Renner; A C Sewell; K Bervoets; H Förster; H Böhles
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.